MRCM
PMD

Mill Road Capital Management’s Psychemedics Corporation PMD Stock Holding History

Mill Road Capital Management’s Portfolio PMD Stock Details PMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-14,896
Closed -$209K – 8
2019
Q1 		$209K Hold
14,896
– – 0.27% 10
2018
Q4 		$236K Hold
14,896
– – 0.3% 12
2018
Q3 		$280K Sell
14,896
-15,106
-50% -$301K 0.21% 12
2018
Q2 		$577K Sell
30,002
-2,566
-8% -$52K 0.35% 11
2018
Q1 		$696K Buy
+32,568
New +$676K 0.56% 11

Other funds holding PMD

KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TCM
Tieton Capital Management Yakima, Washington $299M AUM 54.55% 1-Year Est. Return
CIC
Crawford Investment Counsel Atlanta, Georgia $5.85B AUM 12.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DRZID
DePrince Race & Zollo Inc (DRZ) Winter Park, Florida $5.29B AUM 20.14% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UIC
Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return

Mill Road Capital Management's PMD Position: Q2 2019 in Review

Mill Road Capital Management sold out of Psychemedics Corporation (PMD) in Q2 2019, closing a stake of 14,896 shares — an estimated $209K sold.

Mill Road Capital Management first reported a position in PMD in Q1 2018 and held it in 5 quarters. The position peaked at $696K in Q1 2018. 46 funds tracked by Wall St. Rank hold PMD as of Q2 2019.

  • Mill Road Capital Management reported no remaining Psychemedics Corporation position as of Q2 2019 after selling out during the quarter.
  • Mill Road Capital Management sold 14,896 Psychemedics Corporation shares in Q2 2019, an estimated $209K.
  • Mill Road Capital Management first reported a position in Psychemedics Corporation in Q1 2018 and held it in 5 quarters.
  • Mill Road Capital Management's Psychemedics Corporation position peaked at $696K in Q1 2018.
  • 46 funds tracked by Wall St. Rank held Psychemedics Corporation as of Q2 2019.

Based on Mill Road Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.